Serum Institute of India (SII) | Page 4 | The Business Standard

FILE PHOTO: A man walks past a signpost of India's Serum Institute, the world's largest maker of vaccines, which is developing a vaccine against the coronavirus disease (Covid-19) at its laboratory in Pune, India, May 18, 2020. REUTERS/Euan Rocha

Coronavirus chronicle

AstraZeneca 'sends legal notice' to Serum for vaccine delays

SII CEO said the Indian government's pause on major Covishield shipments to other countries and the "first claim" deal with India were difficult to explain abroad, where the vaccine...

The Serum Institute was founded by Adar Poonawalla's father Cyrus Poonawalla in 1966 Photo: Reuters

Coronavirus chronicle

‘Very stressed’: Serum Institute CEO on India’s vaccine production

Coronavirus chronicle

EU seeks 10 mln AstraZeneca vaccines from India to meet shortfall - Indian source

The vaccine allegedly "stimulates broad antibody and T cell functions Photo: Medical Xpress

Coronavirus chronicle

India AstraZeneca shot delay could be 'catastrophic' for Africa: Health official

The production of line for vials of Covishield at the Serum Institute of India Ltd. Hadaspar plant in Pune, India, on Jan. 22. Photographer: Dhiraj Singh/Bloomberg

Coronavirus chronicle

Covax expects full vaccine supplies from India's Serum in May, says Unicef

AstraZeneca said its vaccine shows no evidence of increased risk of blood clots.

Coronavirus chronicle

'Helpless': alarm after India delays vaccines to COVAX programme for poor countries

Coronavirus chronicle

India delays big exports of AstraZeneca shot as infections surge, sources say

FILE PHOTO: A man walks past a signpost of India's Serum Institute, the world's largest maker of vaccines, which is developing a vaccine against the coronavirus disease (Covid-19) at its laboratory in Pune, India, May 18, 2020. REUTERS/Euan Rocha

Coronavirus chronicle

India's Serum to delay further vaccine shipments to Brazil, Morocco, Saudi

Patients could be discharged early from hospital under the government’s plan. Photograph: Nick Moore/Alamy Stock Photo

Coronavirus chronicle

India shortfall behind UK's Covid vaccine supply delay

There was also a mock drill of conducting vaccination and reporting and review meetings at the block, district and state levels. Picture: Hindustan Times

Coronavirus chronicle

No clotting case in India after Oxford dose

FILE PHOTO: A man walks past a signpost of India's Serum Institute, the world's largest maker of vaccines, which is developing a vaccine against the coronavirus disease (Covid-19) at its laboratory in Pune, India, May 18, 2020. REUTERS/Euan Rocha

Coronavirus chronicle

Indian vaccine giant SII warns of supply hit from US raw materials export ban

A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo

Coronavirus chronicle

UK to receive 10 million AstraZeneca Covid-19 vaccine doses from India's Serum Institute

FILE PHOTO: An employee in personal protective equipment (PPE) removes vials of AstraZeneca's COVISHIELD, coronavirus disease (Covid-19) vaccine from a visual inspection machine inside a lab at Serum Institute of India, Pune, India, November 30, 2020. REUTERS/Francis Mascarenhas

South Asia

Chinese hackers target Indian vaccine makers SII, Bharat Biotech, says security firm